Assets Under Advice | Fees for 3years | |
35 lacs to 99 lacs | 3% + GST | |
1 Cr to 2.99 Cr | 2.5% + GST | |
3 Cr to 9.99 Cr | 2% + GST | |
10 Cr + | Customised Fees | |
GST @ 18% | ||
|
Please contact us for details | ||
|
Indoco Remedies is currently trading at Rs. 188.00, up by 23.45 points or 14.25% from its previous closing of Rs. 164.55 on the BSE.
The scrip opened at Rs. 179.00 and has touched a high and low of Rs. 197.00 and Rs. 178.00 respectively. So far 131021 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 2 has touched a 52 week high of Rs. 197.00 on 22-Jul-2014 and a 52 week low of Rs. 55.05 on 31-Jul-2013.
Last one week high and low of the scrip stood at Rs. 197.00 and Rs. 155.60 respectively. The current market cap of the company is Rs. 1516.33 crore.
The promoters holding in the company stood at 59.20% while Institutions and Non-Institutions held 18.45% and 22.35% respectively.
Indoco Remedies has received Establishment Inspection Report (EIR) from USFDA approving the company’s sterile manufacturing facility (Plant II) and solid dosage manufacturing facility (Plant III) located in Verna, Goa. Last year in August, the USFDA had carried out inspection in the said plant.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1687.55 |
Dr. Reddys Lab | 1109.15 |
Cipla | 1463.15 |
Lupin | 1969.05 |
Zydus Lifesciences | 868.25 |
View more.. |